Alto Neuroscience, Inc. (ANRO)

NYSE: ANRO · Real-Time Price · USD

24.47

+0.20 (0.82%)

At close: Apr 28, 2026, 4:00 PM EDT

24.47

0.00 (0.00%)

After-hours: Apr 28, 2026, 4:00 PM EDT

Alto Neuroscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	-	-	-	0.21
Gross Profit	-	-	-	-	0.21
Selling, General & Admin	20.75	21.61	7.52	5.5	3.9
Research & Development	45.62	47	30.29	23.69	8.37
Operating Expenses	66.36	68.61	37.81	29.19	12.27
Operating Income	-66.36	-68.61	-37.81	-29.19	-12.06
Interest Expense	-2.47	-1.38	-1.37	-	-
Interest & Investment Income	6.6	8.85	2.35	0.11	0
Other Non Operating Income (Expenses)	-0.33	-0.3	0.53	1.37	2.87
EBT Excluding Unusual Items	-62.56	-61.43	-36.31	-27.71	-9.19
Other Unusual Items	-0.68	-	-	-	-
Pretax Income	-63.24	-61.43	-36.31	-27.71	-9.19
Net Income	-63.24	-61.43	-36.31	-27.71	-9.19
Net Income to Common	-63.24	-61.43	-36.31	-27.71	-9.19
Shares Outstanding (Basic)	29	25	4	3	2
Shares Outstanding (Diluted)	29	25	4	3	2
Shares Change (YoY)	17.27%	559.39%	8.27%	42.78%	-
EPS (Basic)	-2.19	-2.50	-9.73	-8.04	-3.81
EPS (Diluted)	-2.19	-2.50	-9.73	-8.04	-3.81
Free Cash Flow	-51.79	-49.5	-33.92	-21.13	-9.94
Free Cash Flow Per Share	-1.79	-2.01	-9.09	-6.13	-4.12
Gross Margin	-	-	-	-	100.00%
Operating Margin	-	-	-	-	-5740.95%
Profit Margin	-	-	-	-	-4374.76%
Free Cash Flow Margin	-	-	-	-	-4734.29%
EBITDA	-65.7	-68.11	-37.44	-28.85	-11.91
D&A For EBITDA	0.66	0.5	0.37	0.34	0.15
EBIT	-66.36	-68.61	-37.81	-29.19	-12.06

Source: S&P Capital IQ. Standard template. Financial Sources.